HealthcareVor Bio stock rallies post-market on trem-cel study dataBy Helitra.com·September 7, 2024·1 min read Vor Bio stock rallies post-market on trem-cel study data Source: SeekingalphaADVERTISEMENT ADVERTISEMENTBio data postmarket rallies stock study tremcel Vor Post navigation Previous storyaTyr started at buy by Jefferies, citing efzofitimod potentialNext storyAscendis raised to outperform by Oppenheimer ahead of drug launch
Fitness · HealthcareReady to have a baby? Here’s what experts say helps improve fertilityNovember 13, 2026So you’ve decided to have a baby. Congrats! But sometimes, it’s not that easy, and you might wonder how to increase your fertility…
Fitness · HealthcareWe Asked A Pelvic Floor Expert To Answer Your Most Embarrassing QuestionsNovember 13, 2026Painful sex. Peeing when you cough. Lower back pain. They may seem like unrelated issues, but all three are common symptoms that can…
Fitness · Healthcare6 Signs Your Child Might Be a People-Pleaser—and Why Experts Say It’s Important to Recognize Them EarlyNovember 13, 2026Reviewed by Wayne Fleisig, Ph.D. Key Takeaways People-pleasing in kids can lead to anxiety, low self-esteem, and difficulty setting boundaries as they grow…